HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Background: Breast cancer in very young women (BCVY) defined as <35 years old, presents with different molecular biology than in older patients. High HDAC5 expression has been associated with poor prognosis in breast cancer (BC) tissue. We aimed to analyze HDAC5 expression in BCVY and older patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072585/
https://www.ncbi.nlm.nih.gov/pubmed/32050699
http://dx.doi.org/10.3390/cancers12020412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072585/
https://www.ncbi.nlm.nih.gov/pubmed/32050699
http://dx.doi.org/10.3390/cancers12020412

Ejemplares similares